GLP-1 receptor agonists, such as semaglutide and liraglutide, are primarily used to manage type 2 diabetes and have been shown to aid in weight loss
Allulose as a functional sugar substitute: Current status and future perspectives
Riboflavin (B2): Supports healthy metabolism and helps convert food into energy
Then together, you can make a plan of what to monitor and what foods or supplementation to prioritize, says Cardel
Patients are strongly advised to: Avoid purchasing either compound from unregulated online sources Discuss weight management or body composition concerns with their GP , who can refer to NHS-commissioned weight management services or advise on licensed alternatives Seek information about legitimate clinical trials through the NIHR's Be Part of Research portal (www.bepartofresearch.nihr.ac.uk), which lists UK-based studies that may be recruiting Report any suspected adverse effects from unlicensed peptides or any medicine to the MHRA via the Yellow Card scheme at Which Option May Be More Suitable for Your Needs
In participants with type 2 diabetes, treatment resulted in HbA1c reductions up to 2.2% at 36 weeks, with mean reductions of 1.24% across pooled analyses
